MeSH tree: D03.633.100.759.758
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that caffeine can restore social memory impaired by sleep deprivation by targeting a defined brain pathway. ...
Mar 24, 2026
0
20
Paraxanthine, a compound the body naturally produces when it breaks down caffeine, is starting to appear in energy drinks and even some coffee products as a potential caffeine alternative.
Mar 16, 2026
0
9
A condition once called the "disease of kings" is affecting even the general population. Rates of gout, a type of inflammatory arthritis that causes severe, sudden stabbing pain in the big toe, have increased by more than ...
Mar 2, 2026
0
14
Scientists have found that drinking two to three cups of coffee a day may significantly reduce your risk of developing dementia, but drinking more won't help protect your brain any further.
Feb 15, 2026
0
26
New research indicates that a drug commonly prescribed for gout may also lower the risk of heart attack and stroke when taken at an appropriate dose.
Feb 9, 2026
0
10
A new prospective cohort study by investigators from Mass General Brigham, Harvard T.H. Chan School of Public Health, and the Broad Institute of MIT and Harvard analyzed 131,821 participants from the Nurses' Health Study ...
Feb 9, 2026
0
147
Coffee first entered human lives and veins over 600 years ago.
Feb 2, 2026
0
33
A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for encephalitis (brain inflammation) caused by herpes simplex virus (HSV) does not improve long-term outcomes ...
Jan 21, 2026
0
11
A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect the risk in pregnant mothers of transmitting cytomegalovirus (CMV)—a common herpes infection ...
Jan 7, 2026
0
6
New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional US centers, report greater cognitive worsening at 78 weeks with valacyclovir than with placebo among ...
